Scarica l'app Stockscreener
0.6283
27.08%
-0.2117
Precedente Chiudi:
$0.84
Aprire:
$0.6668
Volume 24 ore:
29.44M
Relative Volume:
1.28
Capitalizzazione di mercato:
$26.81M
Reddito:
-
Utile/perdita netta:
$-22.71M
Rapporto P/E:
-0.0537
EPS:
-11.71
Flusso di cassa netto:
$-18.24M
1 W Prestazione:
+164.81%
1M Prestazione:
+125.35%
6M Prestazione:
+139.73%
1 anno Prestazione:
+77.59%
Intervallo 1D:
$0.55
$0.6854
Intervallo di 1 settimana:
$0.17
$1.10
Portata 52W:
$0.14
$3.97
Genprex Inc Stock (GNPX) Company Profile
Nome
Genprex Inc
Settore
Industria
Telefono
512-537-7997
Indirizzo
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Confronta GNPX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
0.6248 | 10.83M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
410.71 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
484.08 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.33 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
824.45 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.28 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-01-26 | Iniziato | National Securities | Buy |
| 2019-04-29 | Iniziato | Noble Capital Markets | Outperform |
Genprex Inc Borsa (GNPX) Ultime notizie
What institutional flow reveals about Genprex Inc.Portfolio Gains Summary & Target Return Focused Stock Picks - newser.com
Key metrics from Genprex Inc.’s quarterly dataGap Up & Free High Accuracy Swing Entry Alerts - newser.com
Will Genprex Inc. stock deliver consistent dividendsPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
Gene Therapy Stock Genprex, Inc. (NASDAQ: GNPX) Makes Nasdaq Top Gainers List on News of Positive Preclinical Data on the Use of Reqorsa - Investorideas.com
Genprex (GNPX) Stock Soars on Lung Cancer Gene Therapy Data - parameter.io
Evaluating Genprex Inc. with trendline analysisTrade Performance Summary & Precise Swing Trade Alerts - newser.com
Genprex (NASDAQ:GNPX) Stock Skyrockets 40% on Lung Cancer Gene Therapy Breakthrough - ts2.tech
Genprex (GNPX) Shares Jump 41% After Hours Following New Cancer Therapy Data - Benzinga
Why Genprex Inc. stock is popular among millennialsWeekly Trend Recap & Real-Time Buy Signal Alerts - newser.com
How Genprex Inc. stock responds to policy changesEarnings Recap Report & Verified Chart Pattern Signals - newser.com
Is now a turning point for Genprex Inc.Weekly Trend Report & Entry Point Strategy Guides - newser.com
Pre-market Movers: GNPX, BFRI, DBVT See Big Swings - RTTNews
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EROTC International Conference on Molecular Targets and Cancer Therapeutics - Star Local Media
Using portfolio simulators with Genprex Inc. includedMarket Risk Summary & Technical Buy Zone Confirmations - newser.com
How to forecast Genprex Inc. trends using time seriesPortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com
Heatmap analysis for Genprex Inc. and competitorsJuly 2025 Catalysts & Growth Focused Entry Point Reports - newser.com
What to expect from Genprex Inc. in the next 30 daysJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com
Is Genprex Inc. still worth holding after the dipQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
How high can Genprex Inc. stock goMarket Movers & Growth Focused Stock Pick Reports - newser.com
Can Genprex Inc. stock resist market sell offsJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com
Is Genprex Inc. (2DE0) stock a top hedge fund pickTrade Entry Report & High Conviction Trade Alerts - newser.com
Analyzing net buyer seller activity in Genprex Inc.2025 Sector Review & Growth Oriented Trade Recommendations - newser.com
Risk vs reward if holding onto Genprex Inc.Market Volume Summary & Expert Curated Trade Setups - newser.com
Non-Viral Transfection Reagents Industry Report 2025, with Profiles of Altogen Biosystems, BEX, BTX, Celsion, Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene, OZ Biosciences & MoreResearchAndMarkets.com - FinancialContent
Is Genprex Inc a good long term investmentDividend Stock Watch & Superior Wealth Strategies - earlytimes.in
What analysts say about Genprex Inc stockRetail Investor Activity & Invest Now – Opportunity Window Closing - earlytimes.in
What drives Genprex Inc 2DE0 stock priceIPO Market Watch & Claim Your Custom Stock Report Now - earlytimes.in
Genprex Inc Azioni (GNPX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):